RCM and credentialing aren't sold by lining up features — they're sold by becoming the team a CFO trusts with the most operational pain in their P&L. Built on Musk's deletion discipline, Jensen's flat-structure signal, and Bezos's narrative method.
CHS sales motions stall in predictable places. Symptoms look different — long discovery, ghosted proposals, stuck legal review — but the root cause is almost always the same: we're selling services when we should be selling P&L outcomes. CFOs and Revenue Cycle VPs don't buy "RCM expertise." They buy denial reduction, AR compression, and credentialing speed measured in days saved and dollars recovered.
Five symptoms keep recurring across deals. They look like five problems. They're not.
The fix is structural, not motivational. Build the operating system around CFO economics, not service inventory.
Each part is modular. Implement in sequence or start with the pillar where the team's losing the most deals today (for most CHS sales orgs, that's Pillar 03 — the buying committee map).
Six-stage pipeline with explicit entry/exit criteria, SLAs, named owners, and forecasting categories tuned to CHS deal cycles.
Pipeline · Forecast · SLAsTop-5-Things from AEs every Monday. CEO sees market shifts in week 1: denial trends, payer policy changes, peer hospital signals.
T5T · Market SignalHow a hospital actually buys RCM. Champion → Economic Buyer → Approval committee. Mapped in writing before any proposal.
★ The Star PillarManagers stop relaying status and start developing AEs. Measured on coaching velocity, not just quota attainment.
Player-Coach · ScorecardA/B/C tiering on eight measurable dimensions tuned for healthcare-services sales — including CFO fluency and denial-economics literacy.
A/B/C · Quarterly ReviewDaily norms, weekly time blocks, and an explicit stop-doing list — for the CEO operating a CHS revenue org.
Daily Norms · Stop-DoingSix stages tuned to how RCM and credentialing actually buy. Each has explicit entry criteria, exit criteria, an SLA, and a named owner. Click any stage to inspect.
Four recurring forums plus T5T. Each forum has a single decision mandate, a hard agenda, and required pre-reads. No status updates — those live in the system.
Stage 3–5 deals only. Pre-reads required. Every deal ends with a named owner and a committed date.
One real deal analyzed in front of the group. Public feedback. Skill drill at the end. No performance reviews.
Review 5 randomly-pulled deals for quality of discovery, narrative, and stage compliance. One process improvement committed.
Full A/B/C review across 8 dimensions. A Player investment plans. C Player resolution. Forecast recast.
Most CHS deals stall not because the work is wrong but because the buying committee was never mapped. Champion ≠ Economic Buyer. Decision-maker ≠ Approver. The team that maps the politics in writing before Stage 3 wins twice as often as the team that doesn't.
Lives the pain daily. Has authority over the work but not over the budget. Wants this to happen but can't make it happen alone.
Owns the budget and the P&L outcome. Doesn't want to learn RCM operations — wants to see numbers move on a quarterly board pack.
Often the swing vote on multi-year managed services contracts. Cares about org capacity and operational risk.
Can't say yes, can absolutely say no. Manage proactively or they sink the deal at signature.
CHS sales managers traditionally spend 60% of their week on status meetings, CRM hygiene checks, and information relay. None of that develops AEs. The redesign collapses the routing work into systems and makes the manager into a player-coach measured on AE development velocity, not just quota.
Quarterly A/B/C calibration on eight dimensions specific to healthcare services sales. Each tier gets a different management contract — A players get autonomy and investment, B players get specific development plans, C players get a 30-day window to resolve.
Ten non-negotiable rules for the CEO operating a CHS revenue org. These exist to make the right action obvious in the moment when speed and judgment are both at stake.
The CEO is in the field on real deals — not as observer, as active participant. The market signal degrades fast when the CEO disappears into internal meetings.
Personal response to every submission. If you miss a week, the system starts to decay and you lose the org's most valuable signal source.
For deals over $X ACV, the CEO owns the CFO relationship through signing. Champions love the AE, CFOs sign contracts with peers.
90-day outcome in the customer's language, in their numbers. Bezos PR/FAQ method. If we can't write it, we don't understand the deal.
Stage gates are not suggestions. If an AE pushes for stage advancement without criteria, the right answer is "what's missing?" — not "OK, just for forecast."
If T5T sounds worried, deal is Best Case — not Commit. Forecast accuracy beats forecast optimism every quarter.
Bezos rule. Bring disagreement to the room. Once decided, full commitment. Quiet disagreement after a decision is a leadership failure.
Champion ≠ Economic Buyer. Decision-maker ≠ Approver. If we can't name them by role and person, we're not in Stage 4 yet.
Account Manager owns. Service Manager provides the health snapshot. Surprise non-renewals are a system failure, not a customer problem.
Standards live in what we tolerate. Visible C-player resolution is the loudest signal of organizational seriousness. A players notice — and they stay.
The CHS Revenue OS is the sister system to CHS Operations OS — sales gets the yes; operations makes the yes worth something. Both operate on the same discipline: T5T as signal, narrative as method, deletion as default, cycle time as the metric.